Epidemiology of COVID-19 Among Children in China
- PMID: 32179660
- DOI: 10.1542/peds.2020-0702
Epidemiology of COVID-19 Among Children in China
Abstract
Objective: To identify the epidemiological characteristics and transmission patterns of pediatric patients with the 2019 novel coronavirus disease (COVID-19) in China.
Methods: Nationwide case series of 2135 pediatric patients with COVID-19 reported to the Chinese Center for Disease Control and Prevention from January 16, 2020, to February 8, 2020, were included. The epidemic curves were constructed by key dates of disease onset and case diagnosis. Onset-to-diagnosis curves were constructed by fitting a log-normal distribution to data on both onset and diagnosis dates.
Results: There were 728 (34.1%) laboratory-confirmed cases and 1407 (65.9%) suspected cases. The median age of all patients was 7 years (interquartile range: 2-13 years), and 1208 case patients (56.6%) were boys. More than 90% of all patients had asymptomatic, mild, or moderate cases. The median time from illness onset to diagnoses was 2 days (range: 0-42 days). There was a rapid increase of disease at the early stage of the epidemic, and then there was a gradual and steady decrease. The disease rapidly spread from Hubei province to surrounding provinces over time. More children were infected in Hubei province than any other province.
Conclusions: Children of all ages appeared susceptible to COVID-19, and there was no significant sex difference. Although clinical manifestations of children's COVID-19 cases were generally less severe than those of adult patients, young children, particularly infants, were vulnerable to infection. The distribution of children's COVID-19 cases varied with time and space, and most of the cases were concentrated in Hubei province and surrounding areas. Furthermore, this study provides strong evidence of human-to-human transmission.
Copyright © 2020 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Comment in
-
COVID-19 in Children: Initial Characterization of the Pediatric Disease.Pediatrics. 2020 Jun;145(6):e20200834. doi: 10.1542/peds.2020-0834. Epub 2020 Mar 16. Pediatrics. 2020. PMID: 32179659 No abstract available.
-
Clinical and epidemiological characteristics of children with COVID-19.Nat Med. 2020 Apr;26(4):465. doi: 10.1038/s41591-020-0846-z. Nat Med. 2020. PMID: 32273605 No abstract available.
-
Can Hepatitis A Vaccine Provide Protection Against COVID-19?Exp Clin Transplant. 2020 Apr;18(2):141-143. doi: 10.6002/ect.2020.0109. Exp Clin Transplant. 2020. PMID: 32279655 No abstract available.
-
Children with Covid-19 in Pediatric Emergency Departments in Italy.N Engl J Med. 2020 Jul 9;383(2):187-190. doi: 10.1056/NEJMc2007617. Epub 2020 May 1. N Engl J Med. 2020. PMID: 32356945 Free PMC article. No abstract available.
-
Estimating severe and critical illness in children with COVID-19.Early Hum Dev. 2020 May;144:105052. doi: 10.1016/j.earlhumdev.2020.105052. Epub 2020 Apr 24. Early Hum Dev. 2020. PMID: 32360077 Free PMC article. No abstract available.
-
Can SARS-CoV-2 cause life-threatening bronchiolitis in infants?Pediatr Pulmonol. 2020 Nov;55(11):2842-2843. doi: 10.1002/ppul.25030. Epub 2020 Sep 4. Pediatr Pulmonol. 2020. PMID: 32886863 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical